(Total Views: 400)
Posted On: 02/28/2020 7:27:16 AM
Post# of 154158
Ohm,
Great post, with a god quantity of very interesting material; thanks.
Obviously you have done lots of DD on the matter.
Let me take the opportunity to say that you were right regarding the role of CCR5 in the possible COVID-19 treatment. After the publication of the IIT paper I was assuming that the similarity of the 4 inserts spike protein's in the COVID-19 to HIV-1 would result in an CCR5 antagonist being useful.
Dr. Patterson ulterior conference appearance stated clearly that it was not the HIV-like action (in the CCR5 receptor sense) but rather the anti-inflammatory effect in the respiratory tract that makes Leronlimab a very god candidate in the armory to fight the disease.
The documents in the links you shared are a good addition to the argument, once again, thanks for sharing your research.
Let's hope we can cross the Rubicon soon and inject some patients in China or South Korea and learn that Leronlimabs is indeed effective in helping to treat so many patients in need.
Great post, with a god quantity of very interesting material; thanks.
Obviously you have done lots of DD on the matter.
Let me take the opportunity to say that you were right regarding the role of CCR5 in the possible COVID-19 treatment. After the publication of the IIT paper I was assuming that the similarity of the 4 inserts spike protein's in the COVID-19 to HIV-1 would result in an CCR5 antagonist being useful.
Dr. Patterson ulterior conference appearance stated clearly that it was not the HIV-like action (in the CCR5 receptor sense) but rather the anti-inflammatory effect in the respiratory tract that makes Leronlimab a very god candidate in the armory to fight the disease.
The documents in the links you shared are a good addition to the argument, once again, thanks for sharing your research.
Let's hope we can cross the Rubicon soon and inject some patients in China or South Korea and learn that Leronlimabs is indeed effective in helping to treat so many patients in need.
(3)
(0)
